Annalise Enterprise CTB

annalise.ai

Annalise Enterprise CTB is an AI clinical decision-support solution for brain CT images, assisting clinicians to interpret studies by detecting up to 130 findings. It acts as a second pair of eyes providing notification of suspected findings.

**In the US, FDA 510(k) clearance for triage and notification for a subset of the findings, including acute subdural/epidural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage, intraventricular hemorrhage**

Product specifications

Information source: Public
Last updated: Aug. 20, 2023

General
Product name	Annalise Enterprise CTB
Company	annalise.ai
Subspeciality	Neuro
Modality	CT
Disease targeted	Acute subdural/epidural hematoma, Acute subarachnoid hemorrhage, Intra-axial hemorrhage, Intraventricular hemorrhage
Key-features	Hemorrhage and hematoma triage
Suggested use	Before: adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)
Data characteristics
Population
Input	Non-contrast CT
Input format	DICOM
Output
Output format	AI Viewer. Worklist – HL7 or API based output for worklist triage (prioritisation)
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE	Certified, Class IIb , MDR
FDA	510(k) cleared, Class II
Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers